help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pyorala, S.
Right arrow Articles by Uhari, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pyorala, S.
Right arrow Articles by Uhari, M.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 2795-2799, Copyright © 1995 by Endocrine Society

ARTICLES

A review and meta-analysis of hormonal treatment of cryptorchidism

S Pyorala, NP Huttunen and M Uhari
Department of Surgery, Central Hospital of Central Finland, Jyvaskyla.

To assess the effect of LH-releasing hormone (LHRH) and hCG in the treatment of cryptorchidism, 33 articles published in English between 1958-1990 were analyzed. Altogether, 3282 boys with 4524 undescended testes were included in the analysis; 872 boys with 1174 undescended testes were treated in randomized trials. The meta-analysis showed LHRH to be more effective than placebo; the risk ratio was 3.21 [95% confidence interval (CI) of 1.83-5.64] and 2.57 (95% CI, 1.39-4.74) in trials excluding retractile testes, respectively. In the combined randomized trials, the success rate with LHRH was 21% (95% CI, 18-24%), that with hCG was 19% (95% CI, 13-25%), and that with placebo was 4% (95% CI, 2-6%). The effect of the hormonal treatment was overestimated in nonrandomized trials. In conclusion, LHRH is effective in the treatment of cryptorchidism, and hCG is more effective than placebo, but data about the effect are scanty.


This article has been cited by other articles:


Home page
 JAMAHome page
J. P. A. Ioannidis, A.-B. Haidich, M. Pappa, N. Pantazis, S. I. Kokori, M. G. Tektonidou, D. G. Contopoulos-Ioannidis, and J. Lau
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
JAMA, August 15, 2001; 286(7): 821 - 830.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
R. Kunz and A. D Oxman
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
BMJ, October 31, 1998; 317(7167): 1185 - 1190.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society